Evolution of Sleep Quality During the Start of Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnea Syndrome Using Dreem 3 Headband Monitoring

What this Trial Is About

Researchers are investigating how continuous positive airway pressure (CPAP) treatment affects sleep quality, focusing on deep slow-wave sleep (sleep stage N3) in people newly diagnosed with obstructive sleep apnea (OSA). The study examines sleep improvements in real-life conditions over several nights at home, using advanced technology to gather detailed sleep data. This research aims to understand how sleep parameters change during the first weeks of CPAP treatment and whether these changes relate to improvements in sleepiness, quality of life, and treatment adherence. Participants will wear the Dreem 3 headband and a pulse oximeter at home for seven nights before starting CPAP treatment and for at least nine nights during the first month of treatment. They will also wear a glucose sensor and pedometer throughout the study period, before and after beginning CPAP. These devices will track sleep stages, total sleep time, snoring, breathing rate, heart rate, oxygen saturation, glucose levels, and physical activity, allowing a comprehensive assessment of sleep and health changes. During the study, participants will complete health questionnaires before starting CPAP and after one month of treatment. Researchers will measure the duration of deep slow-wave sleep over multiple nights before and after CPAP initiation. This study will provide valuable data on sleep quality evolution, treatment compliance, and health outcomes. The total study period includes one week of baseline measurement and one month of treatment monitoring at home.

Sleep Quality Evolution: Dreem Under CPAP